Jiangsu Hengrui Pharmaceuticals Co.,Ltd (SHA:600276)
China flag China · Delayed Price · Currency is CNY
54.97
+0.79 (1.46%)
Aug 11, 2026, 3:00 PM CST

SHA:600276 Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
32,56431,62927,98522,82021,27525,906
Revenue Growth
11.55%13.02%22.63%7.26%-17.87%-6.59%
Gross Profit
28,09327,18024,10419,25717,77222,150
Operating Income
8,6308,0866,4764,1763,0603,765
Net Income
8,1197,7116,3374,3023,9064,530
Earnings Per Share
1.221.181.000.680.610.71
EPS Growth
11.85%18.00%47.06%11.47%-14.09%-28.28%

Revenue by Geography

Fiscal YearFY 2025
Period EndingDec '25
China
26,859
Foreign
4,771
Total
31,629

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
40,63641,06925,08920,84517,87118,721
Total Debt
67.4774.23110.1675.181,360151.59
Net Cash (Debt)
40,56840,99524,97920,77016,51118,570
Net Cash Growth
68.42%64.12%20.27%25.79%-11.08%13.00%
Net Cash Per Share
6.106.273.943.282.582.91

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
11,46711,2357,4237,6441,2654,219
Capital Expenditures
-2,965-2,962-1,969-1,484-1,992-1,665
Free Cash Flow
8,5028,2735,4546,160-726.912,554
Free Cash Flow Growth
84.30%51.71%-11.47%---11.24%

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
86.27%85.93%86.13%84.39%83.53%85.50%
Operating Margin
26.50%25.57%23.14%18.30%14.38%14.53%
Pretax Margin
28.22%27.53%25.62%20.45%18.65%17.24%
Profit Margin
24.93%24.38%22.64%18.85%18.36%17.49%
FCF Margin
26.11%26.16%19.49%26.99%-3.42%9.86%

Dividends

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Dividend Per Share
0.2000.2000.2000.2000.1600.160
Dividend Per Share Growth
0%0%0%25.00%0%-4.02%
Dividend Yield
0.37%0.34%0.44%0.45%0.42%0.32%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
45.0351.3246.0666.8562.9171.32
Forward PE
39.3738.9949.3456.9449.4552.14
P/FCF Ratio
42.0547.8453.5246.69-126.49
PS Ratio
10.9812.5110.4312.6011.5512.47